Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 52,553 | 64,168 | 61,130 | 56,660 | 53,821 |
| Receivables | 55,284 | 57,487 | 55,520 | 51,535 | 58,022 |
| Other current assets | 21,158 | 20,153 | 20,288 | 19,471 | 18,150 |
| TOTAL | $131,150 | $155,536 | $154,342 | $143,001 | $144,799 |
| Non-Current Assets | |||||
| PPE Net | 1,748,885 | 1,741,632 | 1,721,967 | 1,655,686 | 1,565,722 |
| Investments And Advances | 82,210 | 83,180 | 82,288 | 76,104 | 76,814 |
| Intangibles | 4,128 | 4,203 | 137 | 183 | 273 |
| Other Non-Current Assets | 7,212 | 7,467 | 7,723 | 7,978 | 8,232 |
| TOTAL | $1,842,435 | $1,836,482 | $1,812,115 | $1,739,951 | $1,651,041 |
| Total Assets | $1,973,585 | $1,992,018 | $1,966,457 | $1,882,952 | $1,795,840 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 169,249 | 133,809 | 231,181 | 224,088 | 203,199 |
| Accounts payable and accrued liabilities | 28,664 | 40,771 | 33,512 | 67,552 | 28,779 |
| Accrued Expenses | 4,813 | 8,335 | 8,116 | 5,320 | 9,029 |
| TOTAL | $214,716 | $192,351 | $283,253 | $304,795 | $249,194 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,250,560 | 1,280,112 | 1,165,324 | 1,074,661 | 1,058,754 |
| Deferred Revenues | 11,990 | 9,404 | 10,352 | 7,596 | 7,172 |
| Other Non-Current Liabilities | -38 | -26 | -41 | -29 | -65 |
| TOTAL | $1,298,764 | $1,323,989 | $1,209,172 | $1,118,405 | $1,103,741 |
| Total Liabilities | $1,513,480 | $1,516,340 | $1,492,425 | $1,423,200 | $1,352,935 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,922 | 20,222 | 21,219 | 21,143 | 20,788 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 318,579 | 332,317 | 319,328 | 306,439 | 292,897 |
| Other shareholders' equity | -6,999 | -6,529 | -6,779 | -7,278 | -4,888 |
| TOTAL | $460,105 | $475,678 | $474,032 | $459,752 | $442,905 |
| Total Liabilities And Equity | $1,973,585 | $1,992,018 | $1,966,457 | $1,882,952 | $1,795,840 |